Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2Phase NA 1Phase 1 1

Status

Terminated 2Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Head & Neck 2Tumor-Agnostic 1Thoracic 1Genitourinary 1Endocrine 1Breast 1

Conditions

Thyroid Neoplasms 1Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Neuroendocrine 1Breast Neoplasms 1Advanced Head and Neck Carcinoma 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1198Oxaliplatin 1160Capecitabine 1142Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Interventional × Radiopharmaceuticals × Clear all
NCT06059014 2026-04-24

PRadR

Centre Leon Berard

Phase 1/2 Completed
6 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma

NCT04892303 2025-07-01

Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Recruiting
48 enrolled
Head & Neck

Thyroid Neoplasms

NCT02236910 2024-10-15

Lu-DOTA-TATE

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Unknown
66 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT04538950 2023-09-13

PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy

Mayo Clinic

Phase 1/2 Completed
6 enrolled 6 charts
Tumor-Agnostic

Neoplasms

NCT02325349 2022-07-19

MLAPOCHI

Assistance Publique - Hôpitaux de Paris

Phase 2 Terminated
1 enrolled
Head & NeckThoracic

Advanced Head and Neck Carcinoma

NCT01222416 2017-07-02

PET/CT Evaluation of Treatment Response in Breast Cancer

Vanderbilt-Ingram Cancer Center

Phase NA Terminated
50 enrolled 6 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡